These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 25232236)

  • 1. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.
    Nakamura J; Tanaka T; Kitajima Y; Noshiro H; Miyazaki K
    World J Gastroenterol; 2014 Sep; 20(34):11991-2006. PubMed ID: 25232236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.
    Matuszcak C; Haier J; Hummel R; Lindner K
    World J Gastroenterol; 2014 Oct; 20(38):13658-66. PubMed ID: 25320504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer.
    Sawaki K; Kanda M; Kodera Y
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):657-670. PubMed ID: 29902383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the molecular diagnostics of gastric cancer.
    Kanda M; Kodera Y
    World J Gastroenterol; 2015 Sep; 21(34):9838-52. PubMed ID: 26379391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia.
    Chen X; Lin Z; Xue M; Si J; Chen S
    PLoS One; 2015; 10(7):e0133906. PubMed ID: 26207911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
    Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
    Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
    Coppedè F; Lopomo A; Spisni R; Migliore L
    World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
    Pan HX; Bai HS; Guo Y; Cheng ZY
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenetic mechanisms in gastric cancer.
    Shi J; Qu YP; Hou P
    World J Gastroenterol; 2014 Oct; 20(38):13804-19. PubMed ID: 25320518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker.
    Amini M; Ghorban K; Mokhtarzadeh A; Dadmanesh M; Baradaran B
    Life Sci; 2020 Aug; 254():117774. PubMed ID: 32407843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. eIF4EBP3 was downregulated by methylation and acted as a tumor suppressor by targeting eIF4E/β-catenin in gastric cancer.
    Zhai S; Lin S; Lin Z; Xu J; Ji T; Chen K; Wu K; Liu H; Ying H; Fei W; Wang J; Fu G; Wang Y; Hu X; Cai X
    Gastric Cancer; 2020 May; 23(3):483-496. PubMed ID: 31853750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
    Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
    Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation in cancer: a gene silencing mechanism and the clinical potential of its biomarkers.
    Fukushige S; Horii A
    Tohoku J Exp Med; 2013 Mar; 229(3):173-85. PubMed ID: 23419314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of recent molecular landscape knowledge of gastric cancer.
    Shimizu D; Kanda M; Kodera Y
    Histol Histopathol; 2018 Jan; 33(1):11-26. PubMed ID: 28447336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
    Yang Z; Guo X; Li G; Shi Y; Li L
    Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis.
    Li T; Chen X; Gu M; Deng A; Qian C
    Clin Epigenetics; 2020 Oct; 12(1):161. PubMed ID: 33115518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Epigenetic Markers for Precision Medicine.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA and histone methylation in gastric carcinogenesis.
    Calcagno DQ; Gigek CO; Chen ES; Burbano RR; Smith Mde A
    World J Gastroenterol; 2013 Feb; 19(8):1182-92. PubMed ID: 23482412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.